Back to BlackRock, Inc. BlackRock, Inc.

AMLXAMLX
7 quarters

Position history for BlackRock, Inc.BlackRock, Inc.'s holdings in AMYLYX PHARMACEUTICALS INC

BlackRock, Inc. holds 8.8M shares of AMLX (AMYLYX PHARMACEUTICALS INC), worth $158.5M as of 2026-Q2. The position was decreased (-0.0% shares). AMLX represents 0.0% of BlackRock, Inc.'s portfolio.

Current Value

$158.5M

Current Shares

8.8M

Total Value Change

+$149.9M

Total Shares Change

+6.5M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
8.8M
-0.0%
$158.5M0.0%$17.96
0
2026-Q1
Decreased
8.8M
-2.5%
$122.7M0.0%$14.11
0
2025-Q4
Increased
9.1M
+26.8%
$109.4M0.0%$12.00
37
2025-Q3
Increased
7.1M
+29.6%
$97M0.0%$14.90
38
2025-Q2
Increased
5.5M
+130.8%
$35.3M0.0%$6.33
47
2025-Q1
Increased
2.4M
+4.8%
$8.5M0.0%$3.66
29
2024-Q4
New
2.3M
-
$8.6M0.0%$3.84
38

Other major holders of AMLX: FMR LLC, VIKING GLOBAL INVESTORS LP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used